Press Releases

BOSTON, MA – December 3, 2013 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), today announced that its CEO, Alan Milinazzo will be presenting at the 24th Annual Oppenheimer & Co. Healthcare Conference at the Crowne Plaza Hotel in New York City. The Company will present at 2:45 p.m. ET on Wednesday, December… Read More

Company Strengthens Leadership Team with Addition of Experienced Global Sales Executive   BOSTON, MA – December 2, 2013 – InspireMD Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection systems, today announced the appointment of Rick Olson as Vice President of Global Sales Operations based in the United Kingdom.   Mr…. Read More

Company to Host Investor Event on December 2, 2013 at 5:00 p.m. IST   BOSTON, MA – November 19, 2013 – InspireMD, Inc. (“InspireMD” or the “Company”) (NYSE MKT: NSPR), a leader in embolic protection stents, today announced that it will host an investor event at the Dan Tel Aviv Hotel in Tel Aviv, Israel… Read More

BOSTON, MA – November 11, 2013 – InspireMD Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection stents, today announced financial results for the quarter ended September 30, 2013.   Key Highlights of Recent Events MGuard™ outperformed bare metal and drug eluting stents in all-cause mortality in STEMI patients for the… Read More

Company to Host Conference Call Tomorrow at 5:30 a.m. PT / 8:30 a.m. ET BOSTON, MA – October 29, 2013 – InspireMD, Inc. (“InspireMD” or the “Company”) (NYSE MKT: NSPR), a leader in embolic protection stents, today announced new 12-month results from the MASTER (MGuard for Acute ST Elevation Reperfusion) trial demonstrating that the MGuard outperformed… Read More

BOSTON, MA – October 28, 2013 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection stents, announced today that it will host a conference call to discuss its MASTER trial 12-month follow up data on October 30, 2013 at 8:30 a.m. ET / 5:30 a.m. PT.   Joining the call… Read More

BOSTON, MA – October 24, 2013 – InspireMD Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection stents, announced today that it has filed a $75 million shelf registration statement on Form S-3 with the Securities and Exchange Commission (the “SEC”).  Once declared effective by the SEC, the shelf registration statement… Read More

Funding for expansion of clinical trial and product development strategies   BOSTON, MA – October 24, 2013 – InspireMD Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection stents, today announced that it has secured $10 million in venture debt financing to support expanding its ability to execute on emerging clinical… Read More

BOSTON, MA – October 23, 2013 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection stents, announced today that it will ring the Opening Bell at the New York Stock Exchange on Thursday, October 24, 2013 at 9:30 a.m. ET.   Representing the Company, Alan Milinazzo, Chief Executive Officer, and… Read More